[go: up one dir, main page]

BR9710198A - Contraceptivo oral constituìdo por combinação farmacêutica de estrogênio-androgênio-progestina. - Google Patents

Contraceptivo oral constituìdo por combinação farmacêutica de estrogênio-androgênio-progestina.

Info

Publication number
BR9710198A
BR9710198A BR9710198-2A BR9710198A BR9710198A BR 9710198 A BR9710198 A BR 9710198A BR 9710198 A BR9710198 A BR 9710198A BR 9710198 A BR9710198 A BR 9710198A
Authority
BR
Brazil
Prior art keywords
androgen
estrogen
pharmaceutical combination
progestin
oral contraceptive
Prior art date
Application number
BR9710198-2A
Other languages
English (en)
Inventor
Claude L Hughes Jr.
Manuel J Jayo
Original Assignee
Univ Wake Forest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest filed Critical Univ Wake Forest
Publication of BR9710198A publication Critical patent/BR9710198A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"CONTRACEPTIVO ORAL CONSTITUìDO POR COMBINAçãO FARMACêUTICA DE ESTROGêNIO-ANDROGêNIO-PROGESTINA". Descreve-se métodos e composições para contracepção oral. Certas composições da invenção contêm androgênios, de preferência metil-testosterona, para serem tomadas por usuárias mais jovens de contraceptivos, para inibir os efeitos adversos do uso de contraceptivos orais sobre a densidade mineral óssea.
BR9710198-2A 1996-07-10 1997-07-09 Contraceptivo oral constituìdo por combinação farmacêutica de estrogênio-androgênio-progestina. BR9710198A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/679,764 US5770226A (en) 1996-07-10 1996-07-10 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US9767976 1997-07-09

Publications (1)

Publication Number Publication Date
BR9710198A true BR9710198A (pt) 2000-01-11

Family

ID=24728261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710198-2A BR9710198A (pt) 1996-07-10 1997-07-09 Contraceptivo oral constituìdo por combinação farmacêutica de estrogênio-androgênio-progestina.

Country Status (8)

Country Link
US (2) US5770226A (pt)
EP (1) EP0929295A1 (pt)
JP (1) JP2000516576A (pt)
KR (1) KR20000023633A (pt)
AU (1) AU3655897A (pt)
BR (1) BR9710198A (pt)
CA (1) CA2258525A1 (pt)
WO (1) WO1998001115A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
ID27922A (id) * 1998-06-11 2001-05-03 Endorech Inc KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
AU5181200A (en) * 1999-06-04 2000-12-28 General Hospital Corporation, The Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
PE20010404A1 (es) 1999-06-11 2001-04-09 Watson Pharmaceuticals Inc Combinacion de esteroides androgenicos no orales y compuestos estrogenicos y su uso en mujeres
US6093421A (en) * 1999-08-31 2000-07-25 Biotics Research Corporation Maca and antler for augmenting testosterone levels
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
WO2003041719A1 (en) * 2001-11-15 2003-05-22 Pantarhei Bioscience B.V. Method of contraception in mammalian females and pharmaceutical kit for use in such method
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
DE10317922B4 (de) * 2003-04-17 2009-11-26 Presearch Gmbh Verwendung eines Kombinationspräparates aus oralem Kontrazeptivum und Calcium/Vitamin D
CA2540697A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
EP1761231A1 (en) * 2004-06-07 2007-03-14 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of dub
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
FI3456329T3 (fi) 2005-10-12 2025-02-27 Besins Healthcare Lu Sarl Parannettu testosteronigeeli ja käyttömenetelmä
US8532938B2 (en) * 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US8468029B2 (en) * 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US20070112589A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware User interface for providing assistance related to health
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070299693A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Customized visual marking for medication labeling
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20080004909A1 (en) * 2005-11-30 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems related to nutraceuticals
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20080210748A1 (en) 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
DE102006010329A1 (de) * 2006-03-06 2007-09-13 Höltge, Michael, Dipl.-Med. Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
EP2459187B1 (en) 2009-07-29 2021-01-06 Olsen, Elise Compositions and methods for inhibiting hair growth
GB202107973D0 (en) * 2021-06-03 2021-07-21 Uniq Health Ltd Methods, systems and media for determining a hormone level and a hormonal state of a subjects

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive

Also Published As

Publication number Publication date
KR20000023633A (ko) 2000-04-25
AU3655897A (en) 1998-02-02
JP2000516576A (ja) 2000-12-12
CA2258525A1 (en) 1998-01-15
US5770226A (en) 1998-06-23
EP0929295A4 (pt) 1999-08-18
WO1998001115A1 (en) 1998-01-15
EP0929295A1 (en) 1999-07-21
US5962021A (en) 1999-10-05

Similar Documents

Publication Publication Date Title
BR9710198A (pt) Contraceptivo oral constituìdo por combinação farmacêutica de estrogênio-androgênio-progestina.
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
TW347335B (en) Solid silicone compositions and methods for their preparation and use
BR9813982A (pt) Anticoncepcionais orais contendo antiestrogênio mais progestina
TR199801679T2 (xx) Osteoporoz i�in birle�tirme terapisi.
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
NL300136I1 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
MX9604208A (es) Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel.
ES2073205T3 (es) Agentes con efecto refrigerante fisiologico y compuestos activos apropiados para estos agentes.
SE9504661D0 (sv) New compounds
BR9914251A (pt) Formulações orais de liberação sustentada
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
FR12C0005I2 (fr) Utilisation d'une composition estroprogestative en tant que contraceptif oral
AR019503A1 (es) Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas
BR9815747A (pt) Composição para liberação de aroma
CO5130008A1 (es) Composicion oral compactada famaceuticamente efectiva a base de entacapona, nitecapona y croscarmelasa de sodio y metodo para preparar dicha composicion
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
PT1079790E (pt) Utilizacao de composicoes microbicidas e espermicidas para inactivacao de virus sem envelope
BR9909486A (pt) Compostos calcilìticos
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
AR021845A1 (es) Derivados de 1,3-diaril-2-piridin-2-il-3-(piridin-2-ilamino)-propanol sustituidos, composiciones farmaceuticas y medicamentos que las comprenden, procedimientos para su preparacion, medicamentos que contienen estos compuestos, y su utilizacion para la preparcion de medicamentos
BR9916620A (pt) Derivados de fenetil-5-bromopiridiltiouréia (pbt) e diidroalcoxibenziloxopirimidina (dabo) exibindo atividade espermicida
ES2039377T3 (es) Un supositorio.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]